Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
Oliver
Maria A
MA
García-Delafuente
Celia
C
Cano
Maria E
ME
Pérez-Hernández
Flora
F
Martínez-Martínez
Luis
L
Albertí
Sebastián
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002999:Clone Cells; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization; D004917:Erythromycin / Q000494:pharmacology; D005838:Genotype; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D010641:Phenotype; D013030:Spain / Q000453:epidemiology; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000235:genetics
D000900:Anti-Bacterial Agents; D018942:Macrolides; D004917:Erythromycin